| Sign In | Join Free | My insurersguide.com |
|
| Sign In | Join Free | My insurersguide.com |
|
| Categories | POCT Test Kit |
|---|---|
| Brand Name: | WWHS |
| Model Number: | CK19 |
| Certification: | ISO13485 |
| Place of Origin: | CN |
| MOQ: | 2000 |
| Price: | Negotiable |
| Payment Terms: | L/C, T/T |
| Supply Ability: | 20000 Kits per Week |
| Delivery Time: | 10 Days |
| Packaging Details: | Colorful Paper Box |
| Product Name: | CK19 Rapid Quantitative Test Kit |
| Sample Buffer: | 20 Vials |
| Warranty: | 12 Months |
| Applicable Instruments: | NIR-1000 Dry Fluorescent Immunoassay Analyzer |
| Advantage: | High Sensitivity, High Accuracy |
| Annual Capacity: | 2 Million a year |
CYFRA21-1 CK19 Rapid Quantitative Fluorescence Immunoassay Test
Cassette FIA POCT
Sample requirements
1. Plasma, serum and whole blood can be used as samples. The whole
blood should be collected in a tube containing heparin, citrate or
EDTA as the anticoagulant. If the serum procedure is used, collect
blood in a tube without anticoagulant and allow clotting. Hemolyzed
samples should not be used.
2. Venous blood was collected according to routine laboratory
methods to avoid hemolysis.
3. It is highly recommended to use fresh samples instead of keeping
the samples at room temperature for a long time. After samples were
collected, the detection should be completed within 4 hours at room
temperature (15℃~30℃). The whole blood sample can be stored at
2℃~8℃ for 24 hours. Plasma and serum samples can be stored at 2℃~
8℃ for 7 days, -20℃for 30 days.
4. Before testing, the sample should return to room temperature
(15℃~30℃). The frozen samples should be completely thawed,
rewarming and mixed evenly before use. Repeated freeze-thaw cycles
should be avoided.
WWHS POCT Assay List
| Tumor Marker | ||||||
| cat#. | Product item | Specimen | Reaction Time | Measure Range | Clinical Range | Itended Use |
| 18 | AFP | Serum/Plasma | 15min. | 2.5-200ng/ml | <20ng/ml | pregnancy cancer |
| 19 | CEA | Serum/Plasma | 15min. | 1-200ng/ml | <5ng/ml | colon cancer, colorectal cancer,etc. |
| 20 | NSE | Serum/Plasma | 15min. | 1-400ng/ml | <16ng/ml | non-small cell lung cancer |
| 21 | FOB | fecal specimens | 10min. | 50-1000ng/ml | <100ng/ml | Abnormal recessive gastrointestinal bleeding |
| 22 | PG II | Serum/Plasma | 15min. | 1-100ug/L | PGI/PGII>3.0 | gastric abnormalities |
| 23 | PG I | Serum/Plasma | 15min. | 2.5-200ug/L | >70ng/ml | gastric abnormalities |
| 24 | PSA | Serum/Plasma | 15min. | 0.5-40ng/ml | <4ng/ml | prostate cancer |
| 25 | FPSA | Serum/Plasma | 15min. | 0.1-10ng/ml | <1ng/ml | prostate cancer |
| 26 | CA12-5 | Serum/Plasma | 15min. | 20-500U/ml | <35U/ml | ovarian cancer |
| 27 | CA15-3 | Serum/Plasma | 15min. | 10-400U/ml | < 25 U/mL | breast cancer |
| 28 | HE4 | Serum/Plasma | 15min. | 50-2000pmol/L | <140 pmol/L | ovarian cancer |
| 29 | CA19-9 | Serum/Plasma | 15min. | 10-400U/ml | < 27 U/mL | pancreatic cancer |
| 30 | β-HCG | Serum/Plasma | 15min. | 5-400mIU/ml | <10 mIU/mL | Early pregrancy, ectopic HCG cancer,incomplete abortion |
| 31 | CK19(Cyfra21-1) | Serum/Plasma | 15min. | 0.5-50ng/ml | <2.5ng/ml | non-small cell lung cancer |
|
WWHS SARS-CoV-2 Antigen FIA Rapid Quantitative Test Kit POCT Assay
Ca125 Rapid Quantitative Test Kit Fluorescence Immunoassay Tumor Maker
FIA Quantitative PSA Rapid Test Kit Dry Fluoroimmunoassay Analyser
CYFRA21-1 Colloidal Gold POCT FIA Rapid Test Kit CE Approved IVD Assay
CK19 CYFRA21-1 IVD Rapid Test Kit IFA Colloidal Gold POCT Diagnostic Reagent Cassette
CRP Rapid POCT Test Kit 3000 Tests/Day High Sensitivity 20T Package
InfluenzaB Infection Rapid Fluoroimmunoassay Test Kit WWHS High Sensitivity FIA POCT Assay
FluA High Sensitivity Colloidal Gold Infection Detection WWHS Rapid Test Kits
PG I Rapid Quantitative Test Kit IFA Colloidal Gold CE Approval IVD Blood Diagnostic
CRP POCT FIA and Colloidal Gold Blood Diagnostic Rapid Quantitative Test Kits
